Scope of the Study
Neurodiagnostics is a field of science devoted to recording and studying the electrical activity of the brain and nervous system. It is used to detect neurological disorders involving stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke.
The market study is being classified and major geographies with country level break-up.
GE Healthcare (United States), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (United States), Natus Medical Incorporated (United States), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan) and Mitsar Co., Ltd. (Russia) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Advanced Brain Monitoring (United States), Thermo Fisher Scientific, Inc. (United States), Bio-Rad Laboratories (United States) and QIAGEN N.V. (Netherlands).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Neurodiagnostics market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Neurodiagnostics market by Type, Application and Region.
On the basis of geography, the market of Neurodiagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rise in the Prevalence of Neurological Diseases and Disorders
- Technological Advancements in the Field of Medical Science
- Growing Patient Emphasis on Effective and Early Disease Diagnosis
- High Cost of Neurodiagnostics
- Limitations Associated with Neurodiagnostics
- Development of Healthcare Infrastructure in Emerging Economies
- Growing Geriatric Population Worldwide
- Lack of Skilled Workforce
Market Leaders and their expansionary development strategies
In August 2019, Royal Philips, a global leader in health technology, has announced that it has completed the previously announced acquisition of Carestream Health Inc.’s Healthcare Information Systems (HCIS) business in 26 of the 38 countries in which it operates. Carestream HCIS’s cloud-enabled enterprise imaging platform will expand Philips’ current enterprise diagnostic informatics solutions, including productivity enhancement, imaging data management, and advanced visualization and analysis.
Key Target AudienceNeurodiagnostics Providers, Research Professionals, Emerging Companies, Distributors, Government Body & Associations and End users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase